comparemela.com

Latest Breaking News On - Centessa - Page 1 : comparemela.com

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

BOSTON and LONDON, May 24, 2023(Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management

United statesNew yorkCity ofUnited kingdomKristenk sheppardGewinn nurCentessa pharmaceuticalsGoldman sachsJefferies global healthcareAnnual global healthcare conferenceDana point

Centessa Pharmaceuticals : 2022 UK Annual Report and Accounts

Registered number: 12973576 CENTESSA PHARMACEUTICALS PLC PARENT COMPANY FINANCIAL STATEMENTS FOR THE YEAR ENDED 31. | May 23, 2023

United kingdomUnited statesCarol stuckleyIqbal hussainMary lynne hedleySamarth kulkarniSaurabh sahaBrett zbarRobert mckinnon califfCompany informationManufacturing organizationContract research organizationCompany balance sheetParent companyCentessa pharmaceuticalsContract development

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2023

- Strong clinical momentum and cash runway into 2026 to support multiple clinical readouts across pipeline - Advancing registration program for SerpinPC to treat hemophilia B; Enrolling subjects in

United statesUnited kingdomCity ofKristenk sheppardResearch development expensesCompany lockbodyLockbody technology platformDrug administrationExchange commissionEuropean association for haemophiliaCentessa pharmaceuticalsUpcoming program milestonesSaurabh sahaChief executive officerInvestigational new drugAnnual congress

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Addition of Patrick Yue, MD, as Senior Vice President of Clinical Development, Innovative Medicines

BOSTON and LONDON, March 01, 2023(Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced the appointment

United statesCity ofUnited kingdomDennis riedlPatrick yueKristenk sheppardBeth israel deaconess medical centerStanford university school of medicineCalifornia institute of technology caltechWashington university school of medicineExchange commissionCentessa pharmaceuticalsClinical developmentSenior vice presidentSaurabh sahaChief executive officer

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Presentation at the SVB Securities Global Biopharma Conference

BOSTON and LONDON, Feb. 02, 2023(Nasdaq: CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today announced that members

United statesCity ofUnited kingdomKristenk sheppardSchwierige zeitenCentessa pharmaceuticalsGlobal biopharma conference

vimarsana © 2020. All Rights Reserved.